Silver Book Fact

Gains in healthy years of life and social value from cancer R&D

Fact image

Lakdawala, D, E Sun, A Jena, C Reyes, D Goldman, et al. An Economic Evaluation of the War on Cancer. J Health Econ. 2010; 29(3): 333-46. http://www.sciencedirect.com/science/article/B6V8K-4YH567G-1/2/88c88fbdd7f57d9fe08803ec85397bc0

Reference

Title
An Economic Evaluation of the War on Cancer
Publication
J Health Econ
Publication Date
2010
Authors
Lakdawala, D, E Sun, A Jena, C Reyes, D Goldman, et al.
Volume & Issue
Volume 29, Issue 3
Pages
333-46
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value
  • Economic Value

Related Facts

  • Between August 2004 and July 2014, the FDA approved: Six new anticancer therapeutics Five new uses for previously approved anticancer therapeutics Two new uses for imaging agents One new use for a screening test  
  • “Among women age 65 and over, the percentage who had a mammogram within the preceding 2 years almost tripled from 23% in 1987 to 64% in 2005.”  
  • Survival rates for colon cancer went from 41 percent to 63 percent between 1975 and 1995.  
  • As of July 2014, 18 anticancer drugs received FDA approval after being designated breakthrough therapies.  
  • Cancer death rates for all races/ethnicities and both sexes combined decreased by 2.1% per year from 2002-2004, nearly twice the annual decrease of 1.1% per year from 1993-2002.